Search for Clinical Trial Results
Leukemia, Mast-Cell - 25 Studies Found
Status | Study |
Completed |
Study Name: Phase II Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD Condition: Leukemia, Mast-Cell Date: 2005-09-14 Interventions:
|
Active, not recruiting |
Study Name: Phase II Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia Condition:
Interventions: Drug: Midostaurin Midostaurin is a broad-spectrum protein kinase inhibitor, acting on conventional PKC i |
Recruiting |
Study Name: Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia Condition:
Interventions: Drug: brentuximab vedotin Brentuximab vedotin is an antibody with a covalently attached toxin. The antib |
Active, not recruiting |
Study Name: Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia Condition: Leukemia Date: 2008-10-28 Interventions: Drug: Midostaurin (PKC412) Midostaurin was provided as 25 mg soft gelatin capsules for oral administrati |
Recruiting |
Study Name: Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis Condition:
Interventions: |
Recruiting |
Study Name: Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (advSM) and Relapsed or Refractory Myeloid Malignancies Condition:
|
Completed |
Study Name: Patient-Reported Outcome Questionnaire for Systemic Mastocytosis Condition:
|
Recruiting |
Study Name: Bioelectrical Impedance Measurement for Predicting Treatment Outcome in Patients With Newly Diagnosed Acute Leukemia Condition:
|
Completed |
Study Name: Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies Condition:
Interventions: |
Completed |
Study Name: MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia Condition:
Interventions: |